Lisbon’s Longevity Summit: Lessons in Longevity Practicality

Lisbon’s Longevity Summit: Lessons in Longevity Practicality

At Lisbon’s Longevity Med Summit, the message was clear: the future is already here. From biomarkers to breathwork, the tools for extending healthspan are no longer speculative — they’re practical, tested, and ready to use.

Read More
Blending Human and Machine Intelligence to Personalise Healthy Longevity

Blending Human and Machine Intelligence to Personalise Healthy Longevity

Explore two personalization strategies in healthy longevity: a data-driven “press-the-button” AI model versus Dr Ash Kapoor’s human-first “root-cause” narrative approach, enhanced by AI co-pilots. Which blend of human insight and machine intelligence will best guide your healthspan?

Read More
Dr Ash Kapoor on Root-Cause Longevity Medicine, Trauma & AI-Powered Care

Dr Ash Kapoor on Root-Cause Longevity Medicine, Trauma & AI-Powered Care

In this conversation, Dr Ash Kapoor unveils his “root-cause” approach to longevity medicine—showing how deep patient narratives and trauma insights drive true personalization—and explores AI-powered, multidisciplinary care as the future of healthy aging.

Read More
The Next Frontier in Longevity: Highlights from the Hevolution Summit 2025
Prof Richard Barker Prof Richard Barker

The Next Frontier in Longevity: Highlights from the Hevolution Summit 2025

The Hevolution Summit 2025 in Riyadh brought together global experts to discuss the future of longevity, investment, and healthcare innovation. With Saudi Arabia's Vision 2030 healthcare plan, could the Kingdom become a leader in biomarker-driven longevity regulation? Explore key insights from the event, including breakthroughs in biotech, investment trends, and the challenges ahead.

Read More
Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science
Prof Richard Barker Prof Richard Barker

Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science

Biomarkers are transforming longevity science, offering a way to validate interventions, track biological aging, and shape future healthcare policies. In this interview, Martin O’Dea discusses the latest advancements in biomarker science, the role of AI-driven diagnostics, and the path toward regulatory acceptance. Watch now to explore the future of aging research.

Read More
Biomarkers: The Key to Unlocking Healthy Longevity
Prof Richard Barker Prof Richard Barker

Biomarkers: The Key to Unlocking Healthy Longevity

Since measurable biomarkers are essential for tracking biological aging, assessing disease risk, and validating longevity interventions, they are shaping the future of healthcare. In this article, I explore the challenges of biomarker standardization, recent advances in proteomics, and how biomarker-driven regulation could transform aging research.

Read More
GLP-1 Agonists: Our ChatGPT Moment in Preventive Medicine and Healthy Longevity
Prof Richard Barker Prof Richard Barker

GLP-1 Agonists: Our ChatGPT Moment in Preventive Medicine and Healthy Longevity

Discover how GLP-1 agonists, like Ozempic, are transforming preventive medicine and healthy longevity. Learn about their impact on weight loss, diabetes management, and reducing the risk of cardiovascular, kidney, and neurodegenerative diseases. Explore why this breakthrough is being hailed as our 'ChatGPT moment' in healthcare.

Read More
The Imperative of Female Longevity
Prof Richard Barker Prof Richard Barker

The Imperative of Female Longevity

Explore the imperative of female longevity and the critical role of women's health research. Delve into the impact of menopause and estrogen on aging, discover groundbreaking findings from the Dublin Longevity Summit, and learn how advancements in fertility preservation and anti-aging treatments are set to transform women's healthspan.

Read More
Understanding Polygenic Risk Scores for Advanced Precision Prevention
Prof Richard Barker Prof Richard Barker

Understanding Polygenic Risk Scores for Advanced Precision Prevention

Your genes are not your destiny, but they do hold vital clues to your future. Discover how polygenic risk scores (PRS) are revolutionizing precision prevention by analyzing genetic mutations to predict disease risk. From breast cancer to cardiovascular disease, learn about the latest advancements and challenges in genetic testing and how it can guide more intensive screening and personalized health strategies. Explore the implications of PRS technology and its potential to transform healthcare systems.

Read More